The FDA will require label changes that limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone to adults aged 18 years and older. In addition, the agency will require added safety information highlighting the risks of misuse, abuse, addiction, overdose, death, and slowed or difficult breathing to the “boxed warning”...
Tag: opioids
Post
Opioid Use
Health Canada strengthens safety information for all opioid drugs Health Canada held a Scientific Advisory Panel on Opioid Use and Contraindications, to consider whether the current contraindications for opioid use are sufficient, or whether labelling updates and other actions may be needed to reduce risks to Canadians. After thoroughly assessing the Panel’s recommendations, Health Canada is...